Nicotine patches as a possible treatment for long covid and me/cfs
bioelecmed.biomedcentral.com
Nicotine patches as a possible treatment for long covid and me/cfs
1–10 of 12 posts
Re: Nicotine patches as a possible treatment for long covid and me/cfs
#2Re: Nicotine patches as a possible treatment for long covid and me/cfs
#3Nicotine is highly addictive.
Re: Nicotine patches as a possible treatment for long covid and me/cfs
#4Nicotine is highly addictive.
Nicotine is a fascinating topic. I do wonder if, in the context of massive obesity prevalent in America, society would be better off with nicotine addiction.
Could it be analogous to how caffeine addiction in our history kick started the knowledge work revolution?
Re: Nicotine patches as a possible treatment for long covid and me/cfs
#5Nicotine is highly addictive.
Remember, nicotine!=tobacco
Re: Nicotine patches as a possible treatment for long covid and me/cfs
#6Nicotine is highly addictive.
Well, if the choice is between “[being] unable to proceed with common everyday activities due to weakness, memory lapses, pain, dyspnea and other unspecific physical complaints” and addicted to a substance that itself has mild side effects, I suspect many would choose the addiction. Remember, nicotine!=tobacco
Re: Nicotine patches as a possible treatment for long covid and me/cfs
#7Nicotine is highly addictive.
So are a lot of medications, I'm not sure what point you're trying to make. Can you elaborate on why you thought it was important to comment?
Re: Nicotine patches as a possible treatment for long covid and me/cfs
#8Nicotine is highly addictive.
Re: Nicotine patches as a possible treatment for long covid and me/cfs
#9Re: Nicotine patches as a possible treatment for long covid and me/cfs
#10A study with sample size of 4?
“The presentation of four individual case descriptions does not allow for general conclusions to be made about the therapeutic effect of transcutaneous nicotine administration in post-COVD-19 syndrome; this would require double-blinded, randomized studies. Due to the minimal therapeutic intervention, studies such as these have the potential to be carried out rather easily. Due to the lack of blinding, the author believes that the psychosomatic component, which other authors suspect to be a central component of long-haul COVID (Stengel et al. 2021), cannot be safely ruled out as part of the therapeutic effect. However, no symptom-related relapses were observed in a follow-up telephone consultation with the patients three to six months post-intervention.”